Owens & Minor to buy Halyard Health’s infection prevention biz
Owens & Minor agreed to pay $710 million to acquire Halyard Health‘s surgical and infection prevention business.The deal, expected to close during the first quarter next year, adds $1 billion in revenues and $80 million in earnings before interest, taxes, depreciation & amortization to Owen’s & Minor’s books annually.Halyard Health, a global provider of medical supplies and solutions...
ToRead the Full Story, Subscribe to
Access the exclusive LEGAL ERAStories,Editorial and Expert Opinion
Owens & Minor agreed to pay $710 million to acquire Halyard Health‘s surgical and infection prevention business.
The deal, expected to close during the first quarter next year, adds $1 billion in revenues and $80 million in earnings before interest, taxes, depreciation & amortization to Owen’s & Minor’s books annually.
Halyard Health, a global provider of medical supplies and solutions was represented by Majmudar & Partners; wherein the team was led by its Managing Partner Akil Hirani; on the sale of its Indian subsidiary’s Surgical & Infection Prevention business to the Indian subsidiary of a healthcare logistics company, Owens & Minor.
This transaction is a part of Halyard Health’s global sale of its Surgical & Infection Prevention business to Owens & Minor, valued at $710 million.
Alston & Bird LLP represented Halyard Health, Inc. as its US counsel and the team was led by Partner Sarah Ernst.
Khaitan & Co advised Owens & Minor with Partner Ravi Khaitan in its lead as Indian counsel.
Simpson Thacher & Bartlett Partner M. Rogers and Eversheds Sutherland Senior Associate Caroline Clapham acted as US counsel for Owens & Minor.
